Cargando…
Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes
Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS), characterized by the infiltration of mononuclear cells into the CNS and a subsequent inflammation of the brain. Monocytes are implicated in disease pathogenesis not only in their function as potential antigen-prese...
Autores principales: | Fischer, Henrike J., Finck, Tobias L. K., Pellkofer, Hannah L., Reichardt, Holger M., Lühder, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549240/ https://www.ncbi.nlm.nih.gov/pubmed/31191554 http://dx.doi.org/10.3389/fimmu.2019.01200 |
Ejemplares similares
-
Protection of Antigen-Primed Effector T Cells From Glucocorticoid-Induced Apoptosis in Cell Culture and in a Mouse Model of Multiple Sclerosis
por: Bier, Jasmina, et al.
Publicado: (2021) -
The Role of Glucocorticoids in Inflammatory Diseases
por: Reichardt, Sybille D., et al.
Publicado: (2021) -
Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity
por: Montes-Cobos, Elena, et al.
Publicado: (2017) -
Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids
por: Lühder, Fred, et al.
Publicado: (2017) -
The glucocorticoid receptor in recipient cells keeps cytokine secretion in acute graft-versus-host disease at bay
por: Baake, Tina, et al.
Publicado: (2018)